We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
IR spectrum of sample complies with the Reference Spectrum
Complies
m.p.
130.0 - 135.0℃
133.5-134.0℃
Purity (by HPLC)
> 99%
99.68%
Chiral Purity (by HPLC)
> 99%
100.00%
Usage
· Prostaglandin intermediate, is a building block for the preparation of an analog of PGF2 [alpha], a potent and selective anti-glaucoma drug.
· As prostaglandins can cause strong contraction of the uterus, it is applied to full-term pregnancy induced abortion, abortion and contraception, and achieved some results. Prostaglandin treatment of asthma, gastrointestinal ulcer disease, shock, hypertension and cardiovascular disease may have a certain effect, which aroused people's attention.
· The main physiological function of PG PGE2 can induce inflammation, promote local vasodilatation, increased capillary permeability, causing red, swollen, pain, fever and other symptoms. PGE2, PGA2 make arterial smooth muscle relaxation, lower blood pressure. PGE2 and PGI2 inhibit gastric acid secretion, promote gastrointestinal smooth muscle motility. Follicles produce PGE2 and PGF2α play an important role in ovulation. PGF2α can ovarian smooth muscle contraction, causing ovulation. Uterine release of PGF2α luteal lysis. PGF2α released from the endometrium during childbirth can cause contractions of the uterus to be strengthened and promote childbirth.